Zimbabwe has turned down a significant American healthcare agreement valued at 367 million US dollars (£272m) over five years because of Washington's demand for confidential biological samples.
This move became public following a internal memorandum from December was leaked, indicating that President Emmerson Mnangagwa deemed the arrangement was "skewed".
A government spokesman has since explained that the US was seeking genetic material for scientific study and profit while was unwilling to share the resulting advantages from any future medical innovations.
"We are forced to start the difficult and regrettable process of scaling back our health aid in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy indicated the US had donated more than $1.9bn as health assistance to Zimbabwe during the past two decades.
A doctors' association in Zimbabwe has called for continued negotiations to secure a deal agreeable to all parties so the country's critical HIV treatment initiative can be sustained.
Broader Implications
This development follows a similar situation in neighbouring Kenya, where a high court halted a similar deal with the US after legal challenges were raised about the safety of citizens' health data.
Since resuming office recently, US President Donald Trump has reduced overseas assistance and shut down the US Agency for International Development (USAID).
The agency had administered aid for the American government, but Trump claimed its expenditure was "wasteful" and his government was seeking direct bilateral agreements to boost transparency and accountability.
As per reports, 16 nations in Africa have to date agreed to these new health pacts, representing more than $18.3bn in committed funds.
Details of the Declined Agreement
The funds for Zimbabwe was intended to funded "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"It is our view this partnership would have delivered significant advantages for the people of Zimbabwe, especially the 1.2 million men, women and children currently on HIV treatment via US-supported programmes," Tremont added.
However, official spokesman Nick Mangwana argued the arrangement was "unfair".
"Our nation was requested to share its genetic material and health information over an extended period, without any equivalent promise of access to any scientific breakthroughs – such as new medicines or tests – that might be developed from that provided information," he stated.
"Put simply, our country would supply the basic resources for scientific discovery with no certainty that the final treatments would be accessible to our citizens should a new health crisis emerge."
Sovereignty and International Frameworks
He also said that the US's withdrawal from the global health body and its push of bilateral health agreements were undermining systems previously established via the international organization.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing system created to deal with potential global health emergencies.
"This framework is designed to ensure that when a nation provides its samples, the benefits – including medicines and cures – are distributed fairly, not monopolised exclusively by those with the capability to develop them."
These objections regarding the US deal "are not meant as hostility towards the US," he added.
"We encourage ongoing discussions with our American counterparts on how subsequent co-operation could be designed in a way that respects the sovereignty and interests of both nations."
Medical Community Response
Medical experts stated it recognised the government's concerns, but urged that negotiations should continue considering much of the nation's Aids initiatives relied on foreign aid.
"If technical issues arise, such as those involving information security or implementation frameworks, these can often be resolved through technical clarification and mutually agreed protections," the group said.
The situation underscores the ongoing challenges between accepting vital foreign assistance and protecting a country's data in an increasingly data-driven world.